Guardians trade Gold Glove 2B Andres Gimenez to Blue Jays, get Luis Ortiz in deal with Pirates
The 26-year-old Giménez batted .252 with nine homers, 63 RBIs and 30 steals last season. He was acquired by the Guardians as ...
Blue Jays trade for Guardians 2B Andres Gimenez, RHP Nick Sandlin
The Toronto Blue Jays acquired second baseman Andres Gimenez and right-handed pitcher Nick Sandlin through a trade with the ...
Guardians trade Gold Glove 2B Andrés Giménez to Blue Jays, get RHP Luis Ortiz in deal with Pirates
The Cleveland Guardians broke up their infield and plugged a hole in their rotation. Giménez, considered one of baseball’s ...
Report: Blue Jays acquiring 2B Andres Gimenez from Guardians
The Cleveland Guardians are trading three-time Gold Glove-winning second baseman Andres Gimenez to the Toronto Blue Jays, ...
MLive22h
Price tag is $1.2B for University of Michigan, Los Alamos project to build ‘fastest computer’
The national laboratory known for inventing the atomic bomb received a $100 million boost to establish two facilities in ...
Blue Jays trading for Guardians 2B Andres Gimenez
The Toronto Blue Jays agreed to a deal with the Cleveland Guardians for All-Star second baseman Andres Gimenez, sources told ...
AnaptysBio announces Phase 2b trial of ANB032 did not meet primary endpoint
AnaptysBio (ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary endpoints in any of the doses ...
Blue Jays trade for Guardians 2B Andrés Giménez, pitcher Nick Sandlin
BREAKING: The Toronto Blue Jays are finalizing a trade to acquire three-time Gold Glove-winning second baseman Andrés Giménez ...
San Antonio airport breaks ground on $1.2B terminal, aiming to boost travel and economy
Construction is officially underway for a new terminal at the San Antonio international airport. The new terminal will have ...
Blue Jays reportedly trading for Guardians 2B Andrés Giménez
BREAKING: The Toronto Blue Jays are finalizing a trade to acquire three-time Gold Glove-winning second baseman Andrés Giménez ...
CervoMed Phase 2b Study of Neflamapimod Misses Main Endpoints
CervoMed on Tuesday said a mid-stage study of its lead program neflamapimod missed its key goals in the degenerative brain disease dementia with Lewy bodies, or DLB.